+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Neovii Pharmaceuticals AG - logo

Neovii is a global leader in polyclonal antibody immunosuppressive therapy used in organ transplantation and hematology/oncology. It focuses on solid organ transplantation, stem cell transplantation and immune and hemato-oncological disorders. Founded in 2003, Neovii's global headquarters are located in Rapperswil, Switzerland. Its headquarters in the United States are in Waltham, MA. It employs approximately 150 people and has presence in nearly 60 countries worldwide.

Malignant Ascites Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 to 2029 - Product Thumbnail Image

Malignant Ascites Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 to 2029

  • Report
  • May 2021
  • 115 Pages
  • Global
From
Cancer Immunotherapy Global Market Report 2024 - Product Thumbnail Image

Cancer Immunotherapy Global Market Report 2024

  • Report
  • December 2023
  • 200 Pages
  • Global
From
Bone Marrow Transplant Rejection Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Bone Marrow Transplant Rejection Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • April 2022
  • 555 Pages
  • Global
From
Loading Indicator